日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patients

评估高级别胶质瘤患者血脑屏障通透性异质性的窗口期

Oh, Ju-Hee; Reed, Sarah K; Riviere-Cazaux, Cecile; Kim, Minjee; Mladek, Ann C; Illamola, Silvia M; Zhang, Wenjuan; Vaubel, Rachael A; Caron, Alissa; Regan, Michael S; Birnbaum, Angela K; Mohammad, Afroz; Zhang, Wenqiu; Dixon, Jesse G; Kaufmann, Timothy J; Hu, Leland S; Ma, Daniel J; Kizilbash, Sani; Agar, Nathalie Y R; Giannini, Caterina; Geyer, Susan M; Parney, Ian F; Galanis, Evanthia; Burns, Terry C; Elmquist, William F; Sarkaria, Jann N

Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts

MDM2抑制剂brigimadlin在胶质母细胞瘤患者来源异种移植模型中的药代动力学-药效学-疗效模型

Vaubel, Rachael A; Zhang, Wenjuan; Karbhari, Nishika; Oh, Ju-Hee; Waller, Katie L; Mladek, Ann; Jain, Sonia; Burgenske, Danielle M; Decker, Paul A; Kosel, Matt L; Hu, Zeng; Ott, Lauren L; Carlson, Brett L; Bakken, Katrina K; Pasa, Tugce; Sarkaria, Nicole R; Talele, Surabhi; Eckel-Passow, Jeanette E; Sini, Patrizia; Elmquist, William F; Sarkaria, Jann N

The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts

新型脑穿透性共济失调毛细血管扩张症突变抑制剂WSD0628可显著增强脑肿瘤患者来源异种移植瘤的放射敏感性。

Xue, Zhiyi; Mladek, Ann C; Rathi, Sneha; Jain, Sonia; Vaubel, Rachael A; Odukoya, Lateef A; Garcia, Darwin A; Liu, Lily; Bakken, Katrina K; Carlson, Brett L; Ott, Lauren L; Burgenske, Danielle M; Hu, Zeng; Dragojevic, Sonja; Decker, Paul A; Kosel, Matthew L; Breen, William G; Gupta, Shiv K; Eckel-Passow, Jeanette E; Elmquist, William F; Zhong, Wei; Sarkaria, Jann N

Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type Glioblastoma.

Navtemadlin 在 IDH 野生型胶质母细胞瘤中的药代动力学、药效学和疗效的临床前模型

Vaubel Rachael A, Zhang Wenjuan, Oh Ju-Hee, Mladek Ann C, Pasa Tugce I, Gantchev Jennifer K, Waller Katie L, Baquer Gerard, Stopka Sylwia A, Regan Michael S, Hossain Md Amin, Decker Paul A, Kosel Matthew L, Gupta Shiv K, Jain Sonia, Sarkaria Paige P, Hu Zeng, Ott Lauren L, Carlson Brett L, Bakken Katie K, Talele Surabhi, Zhang Wenqiu, Ligon Keith L, Lee Eudocia Q, Eckel Passow Jeanette E, Burgenske Danielle M, Agar Nathalie Y R, Elmquist William F, Sarkaria Jann N

Systems analysis uncovers early temozolomide responses and peptide antigens in glioblastoma

系统分析揭示胶质母细胞瘤中替莫唑胺的早期反应和肽抗原

Choe, Elizabeth Y; Leddy, Owen; Riviere-Cazaux, Cecile; Burgenske, Danielle M; Hu, Zeng; Mladek, Ann C; Fedeles, Bogdan I; Hu, Sabrina; Essigmann, John M; Prins, Robert M; Sarkaria, Jann N; Burns, Terry C; Vaubel, Rachael A; White, Forest M

Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts

DNA-PKcs抑制剂Peposertib的差异性分布选择性地增强患者来源的黑色素瘤脑转移异种移植瘤的放射敏感性

Ji, Jianxiong; Dragojevic, Sonja; Callaghan, Cameron M; Smith, Emily J; Talele, Surabhi; Zhang, Wenjuan; Connors, Margaret A; Mladek, Ann C; Hu, Zeng; Bakken, Katrina K; Sarkaria, Paige P; Carlson, Brett L; Burgenske, Danielle M; Decker, Paul A; Rashid, Mohammad Abdur; Jang, Mi-Hyeon; Gupta, Shiv K; Eckel-Passow, Jeanette E; Elmquist, William F; Sarkaria, Jann N

Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma

治疗脑肿瘤的给药方式与效力:BI-907828,一种 MDM2-p53 拮抗剂,其 BBB 渗透性有限,但在胶质母细胞瘤体内疗效显著

Wenjuan Zhang #, Rachael A Vaubel #, Ju-Hee Oh, Ann C Mladek, Surabhi Talele, Wenqiu Zhang, Katie L Waller, Danielle M Burgenske, Jann N Sarkaria, William F Elmquist

Factors Influencing the Central Nervous System (CNS) Distribution of the Ataxia Telangiectasia Mutated and Rad3-Related Inhibitor Elimusertib (BAY1895344): Implications for the Treatment of CNS Tumors

影响共济失调毛细血管扩张症突变及Rad3相关抑制剂Elimusertib (BAY1895344)在中枢神经系统(CNS)分布的因素:对中枢神经系统肿瘤治疗的启示

Rathi, Sneha; Mladek, Ann C; Oh, Ju-Hee; Dragojevic, Sonja; Burgenske, Danielle M; Zhang, Wenjuan; Talele, Surabhi; Zhang, Wenqiu; Bakken, Katrina K; Carlson, Brett L; Connors, Margaret A; He, Lihong; Hu, Zeng; Sarkaria, Jann N; Elmquist, William F

Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors

ATM抑制剂WSD0628(一种用于治疗脑肿瘤的新型放射增敏剂)的临床前全身药代动力学、剂量比例性和中枢神经系统分布

Rathi, Sneha; Oh, Ju-Hee; Zhang, Wenjuan; Mladek, Ann C; Garcia, Darwin A; Xue, Zhiyi; Burgenske, Danielle M; Zhang, Wenqiu; Le, Jiayan; Zhong, Wei; Sarkaria, Jann N; Elmquist, William F

WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models

WSD-0922 是一种新型的可穿透血脑屏障的表皮生长因子受体抑制剂,能够促进胶质母细胞瘤小鼠模型的存活。

Conage-Pough, Jason E; Stopka, Sylwia A; Oh, Ju-Hee; Mladek, Ann C; Burgenske, Danielle M; Regan, Michael S; Baquer, Gerard; Decker, Paul A; Carlson, Brett L; Bakken, Katrina K; Zhang, Jinqiang; Liu, Lily; Sun, Claire; Mu, Zhihua; Zhong, Wei; Tran, Nhan L; Elmquist, William F; Agar, Nathalie Y R; Sarkaria, Jann N; White, Forest M